Srs Capital Advisors, Inc. Myriad Genetics Inc Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 51 shares of MYGN stock, worth $1,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51Holding current value
$1,378% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
232Shares Held
92.6MCall Options Held
117KPut Options Held
113K-
Black Rock Inc. New York, NY15.2MShares$410 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$272 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$223 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$149 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$119 Million0.05% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.18B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...